amifostine anhydrous has been researched along with Ischemia in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bougioukas, I | 1 |
| Didilis, V | 1 |
| Emigholz, J | 1 |
| Waldmann-Beushausen, R | 1 |
| Stojanovic, T | 1 |
| Mühlfeld, C | 1 |
| Schoendube, FA | 1 |
| Danner, BC | 1 |
1 other study available for amifostine anhydrous and Ischemia
| Article | Year |
|---|---|
The effect of amifostine on lung ischaemia-reperfusion injury in rats.
Topics: Amifostine; Animals; Disease Models, Animal; Inflammation Mediators; Ischemia; Lung; Male; NF-kappa | 2016 |